Hua Hong Semiconductor (01347) Q1 2025 Earnings Call May 08, 2025 05:00 AM ET Speaker0 Ladies and gentlemen, thank you for standing by. Welcome to Huahong Semiconductor First Quarter twenty twenty five Earnings Conference Call. Today's call is hosted by Doctor. Peng Bai, President and Executive Director and Mr. Daniel Wang, Executive Vice President and Chief Financial Officer. Please be advised that your dial ins are in a listen only mode. However, at the conclusions of the management's presentation, there ...

Budweiser Brewing Company APAC (01876) Q1 2025 Earnings Call May 07, 2025 11:30 PM ET Company Participants Yanjun Cheng - CEO & Co-ChairmanIgnacio Lares - Chief Financial OfficerEuan Mcleish - Managing DirectorLeaf Liu - Executive Director Conference Call Participants Chen Luo - AnalystXiaopo Wei - AnalystWenbo Chen - Analyst Operator Welcome to the twenty twenty five first quarter announcement conference call for Budweiser Brewing Company, PAC Limited. Hosting the call today from Budweiser, PAC is mister Y ...

Budweiser Brewing Company APAC (01876) Q1 2025 Earnings Call May 07, 2025 11:30 PM ET Speaker0 Welcome to the twenty twenty five first quarter announcement conference call for Budweiser Brewing Company, PAC Limited. Hosting the call today from Budweiser, PAC is mister YJ Chung, chief executive officer and co chair of the board, and Mr. Ignacio Lares, chief financial officer. The results for three months ended 03/31/2025 can be found in the press release published earlier today and available on the Hong Kong ...

Financial Data and Key Metrics Changes - The Group recorded net revenues of EUR 1.34 billion in the first quarter, up 13% at constant exchange rates compared to the same period last year [9] - Retail sales reached EUR 1.22 billion, also up 13% at constant FX, driven by like-for-like and full-price sales [9] - Wholesale sales increased by 7% year-on-year, while royalties delivered a 13% growth, supported by eyewear and fragrances [10] Business Line Data and Key Metrics Changes - Prada brand's retail sales remained stable against high comparisons from the previous year, while Miu Miu experienced a remarkable growth of 60% at constant FX, increasing its contribution to Group retail sales from 22% to 31% [11][10] - Leather goods were highlighted as one of the fastest-growing categories, particularly for Miu Miu, with significant success in the first three months [29][30] Market Data and Key Metrics Changes - Asia Pacific sales were up 10% at constant FX, Europe increased by 14%, the Americas grew by 10%, and Japan saw an 18% rise, with the Middle East delivering the best performance at 26% [12] - The Chinese market showed volatility, with local transactions negatively impacting performance, while traveler transactions remained positive [20] Company Strategy and Development Direction - The company aims to build Prada's desirability and product innovation to maintain positive growth despite challenging market conditions [4] - Miu Miu's expansion in the U.S. is a focus, with plans for further store openings and refurbishments to enhance brand presence [35] Management's Comments on Operating Environment and Future Outlook - Management noted that the market remains complicated, with regular trends and some differences across regions, but expressed optimism about maintaining positive growth [14] - The company is not expecting significant changes in consumer behavior in the short term but hopes for gradual improvements in local demand, particularly in China [68] Other Important Information - The company is observing pricing strategies closely, considering potential impacts from tariffs and currency fluctuations, with a maintenance pricing strategy of 2-4% every six months [41] - The online channel for both brands has seen growth, particularly in North America, contributing to 8-10% of total revenue [59] Q&A Session Summary Question: Trends by nationality and product brand EBITDA - Management noted volatility in the Chinese cluster, with a return to negative performance in Q1 compared to a strong Q4 [20] Question: Changes in American consumer behavior and future acceleration - Management indicated that the U.S. market remains unstable, with ongoing investments aimed at improving performance [23] Question: Drivers of leather goods growth - Miu Miu's leather goods category showed strong performance, with a mix of iconic and new products driving success [30] Question: Update on store expansion plans - The company confirmed ongoing plans for store expansions, particularly for Miu Miu in North America, with a successful refurbishment of the Soho store [35] Question: Pricing strategy in light of tariffs - Management stated that maintenance pricing increases would likely be sufficient to offset potential tariffs, but consumer confidence remains a concern [50] Question: Overlap between Prada and Miu Miu customer demographics - Management emphasized that both brands are managed independently, with no intentional overlap in customer targeting [54] Question: Profitability outlook and seasonality - Management indicated that growth remains the priority, with a focus on maintaining moderate margin expansion [58] Question: Performance of online channels - Online sales have grown slightly in North America, maintaining a consistent contribution to total revenue [59] Question: Competitive landscape and new product cycles - Management acknowledged the reshuffling in the luxury industry and expressed confidence in gaining market share through stability and creativity [65] Question: Investments in China and local demand outlook - Management remains positive about long-term prospects in China, with expectations for easier comparisons in the second half of the year [68]

Financial Data and Key Metrics Changes - The group achieved revenue of US$401.5 million, meeting the midpoint of revenue guidance [3][7] - Group bookings totaled US$431.2 million, showing a 2.9% quarter-on-quarter growth and 4.8% year-on-year growth [7] - Group gross margin exceeded 40%, rebounding due to a better product mix [6][8] - Adjusted net profit was HKD83.2 million, up 1.6% quarter-on-quarter but down 53.1% year-on-year [9] Business Line Data and Key Metrics Changes - The semiconductor (semi) segment contributed approximately 64% of the group's revenue, with revenue of US$255.6 million, up 0.6% quarter-on-quarter and 44.7% year-on-year [9][10] - Semi bookings were US$222.9 million, down 19.5% quarter-on-quarter but up 11.4% year-on-year [10][11] - The surface mount technology (SMT) segment delivered revenue of US$145.9 million, a decline of 20.3% quarter-on-quarter and 35.6% year-on-year [12] - SMT bookings were US$208.4 million, up 46.5% quarter-on-quarter, driven by strong seasonal demand [12] Market Data and Key Metrics Changes - The mainstream business continued to be affected by soft demand from automotive and industrial end markets, with growth trajectory difficult to forecast [6][14] - The company noted stabilization in the automotive and industrial end markets, although they remained soft [12][14] Company Strategy and Development Direction - The focus for 2025 is on securing additional orders from both high volume manufacturing (HVM) and logic customers [5][14] - The company remains confident in the demand for advanced packaging (AP) and TCB solutions for AI and high-performance computing applications [14][105] - The global manufacturing footprint provides flexibility to navigate potential tariff impacts [14][105] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining AP revenue and expects mainstream business to improve due to seasonality and better-than-expected Q1 bookings [14] - The indirect impact of tariffs makes the growth trajectory difficult to forecast, but management remains optimistic about the overall market growth [14][26] Other Important Information - The company completed the delivery of the bulk of ECB orders to a leading memory maker, with further orders expected [4][5] - The strong progress in DCB solidifies the company's leadership in the market [5] Q&A Session Summary Question: Booking direction in the second quarter and advanced packaging booking momentum - Management remains confident that Q2 bookings will be within a similar range compared to the last few quarters, assuming no unexpected impacts from tariffs [21][22] Question: Impact of tariffs on SMT business and capacity expansion - Management noted that while there hasn't been significant direct impact on operations, some customers are evaluating their investment timing and location due to tariffs [26][27] Question: Magnitude of orders from the second HBM customer - Orders from the second HBM customer are smaller compared to the first but are considered meaningful, with two orders already received [42] Question: Progress on chip on wafer tools and customer decisions - Management indicated significant progress from qualification to pilot production, with expectations for orders in the second half of 2025 [50][52] Question: Confidence in follow-on orders from the leading HBM customer - Management is hopeful for follow-on orders and is actively engaging with multiple HBM players [62] Question: OpEx management and future profitability - Management emphasized a balance between protecting future R&D investments and maintaining sensible cost control measures [99][100]

Hong Kong Exchanges and Clearing (00388) Q1 2025 Earnings Call April 29, 2025 09:30 PM ET Company Participants Carlson Tong - Chairman Conference Call Participants None - Analyst Operator Ladies and gentlemen, the Annual General Meeting will start shortly. Today's meeting will be conducted in English. Please use the headphones to listen to the simultaneous interpretation in Cantonese, Channel two or Pudong Hua, Channel three. For those joining us through the webcast, you may select the corresponding audio c ...

Hong Kong Exchanges and Clearing (00388) Q1 2025 Earnings Call April 29, 2025 09:30 PM ET Speaker0 Ladies and gentlemen, the Annual General Meeting will start shortly. Today's meeting will be conducted in English. Please use the headphones to listen to the simultaneous interpretation in Cantonese, Channel two or Pudong Hua, Channel three. For those joining us through the webcast, you may select the corresponding audio channel on the top right hand corner of your screen Thank you. As mentioned in our circula ...

ASMPT (00522) Q1 2025 Earnings Call April 29, 2025 08:30 PM ET Company Participants Justin Tham - VP & CFORobin Ng - Group CEO & Group Executive DirectorKatie Xu - EVP & Group CFOGokul Hariharan - Managing DirectorLeping Huang - Managing Director Conference Call Participants Donnie Teng - AnalystSunny Lin - AnalystKevin Chen - Analyst Justin Tham Good morning and good evening, ladies and gentlemen. This is Justin Tang, and I will be moderating today's call. On behalf of ASMPT Limited, welcome to our first q ...

Financial Data and Key Metrics Changes - Revenue from continuing operations grew 23.1% year over year to RMB9.39 billion, while total revenue achieved RMB9.65 billion, representing a 21% year over year growth [9] - Adjusted non-IFRS net profit grew 40% year over year to RMB2.68 billion, with a record backlog for continuing operations of RMB52.33 billion, growing 47.1% year over year [9][10] - Adjusted IFRS gross profit margin reached 41.9%, with net profit attributable to the owners of the company increasing by 89.1% year over year [26][27] Business Line Data and Key Metrics Changes - Wuxi Chemistry's CRDMO business revenue grew 32.9% year over year to RMB7.39 billion, with adjusted non-IFRS gross profit margin improving 4.2 percentage points year over year to 47.5% [11][12] - Small molecule DNM business revenue grew 13.8% year over year to RMB3.85 billion, with both Changzhou and Taishin API manufacturing sites passing FDA inspections [13] - Tides business achieved RMB2.24 billion revenue in the first quarter, representing a strong growth of 187.6% year over year [14] Market Data and Key Metrics Changes - Revenue from the U.S. market grew 28.4% year over year, while revenue from Europe grew 26.2% year over year; however, China showed a slight decline [10] - Revenue generated from clinical CRO and SMO business was down 2.2% year over year to RMB0.61 billion, attributed to market price impact [21][22] Company Strategy and Development Direction - The company will continue to focus on the CRDMO business model with an emphasis on operational efficiency and exceptional services [29] - Full year guidance is maintained, expecting revenue from continuing operations to resume double-digit growth of 10% to 15% year over year, targeting total revenue of RMB41.5 billion to RMB43 billion [30] - The company plans to accelerate global D and M capacity expansion, with CapEx expected to reach RMB7 billion to RMB8 billion [30] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining full year guidance despite external uncertainties, emphasizing the importance of operational resilience [30][31] - The company is committed to rewarding shareholders with a proposed 30% annual cash dividend payout ratio and additional one-time special cash dividend [31][32] Other Important Information - The company has successfully supported about 40% of successful out-licensing deals from Chinese biotech since 2022 [20] - The total amount of cash dividends and share repurchases is expected to exceed RMB6 billion, accounting for more than 60% of the company's net profit attributable to owners in 2024 [32] Q&A Session Summary Question: What are the key drivers behind the robust growth in Tides? - The growth is attributed to both strong demand and capacity ramping up from a low base last year [37] Question: How does the company view the impact of tariffs on business segments? - Tariffs are seen as a systemic challenge, with less than 10% of total revenue coming from exports to the U.S. [45][46] Question: What is the projected CapEx for 2025 and its allocation? - Projected CapEx is RMB7 billion to RMB8 billion, primarily for expanding D and M manufacturing capacity in various locations [50][54] Question: How does the company plan to address pricing pressures in testing and biology segments? - The company aims to focus on contracts with higher margins and differentiate its services to improve margins gradually [68] Question: What is the expected contribution from late-stage D and M projects in the next few years? - Specific numbers are difficult to provide, but the CRDMO business model is expected to sustain growth through a strong pipeline [71]

WH Group (00288) Q1 2025 Earnings Call April 29, 2025 04:00 AM ET Speaker0 Dear analysts and investors, good evening, everyone. Welcome to today's earning call of Double H Group for the first quarter of twenty twenty five. This is CEO and President of Double H Group, Goli Jun. Attending today's earnings call include senior management of Double H Group and our subsidiaries, Shanhui Development, Smithfield Foods as well as Morlini Foods. They are Chairman and Executive Director of Double H Group, Chairman, Wa ...